» Articles » PMID: 27498214

Lubricin/proteoglycan 4 Increases in Both Experimental and Naturally Occurring Equine Osteoarthritis

Overview
Date 2016 Aug 8
PMID 27498214
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The goals of this study were (1) to quantify proteoglycan 4 (PRG4) gene expression; (2) to assess lubricin immunostaining; and (3) to measure synovial fluid lubricin concentrations in clinical and experimental models of equine carpal osteoarthritis (OA).

Design: Lubricin synovial fluid concentrations and cartilage and synovial membrane PRG4 expression were analyzed in research horses undergoing experimental OA induction (n = 8) and in equine clinical patients with carpal OA (n = 58). Lubricin concentrations were measured using a custom sandwich enzyme-linked immunosorbent assay, and PRG4 expression was quantified using qRT-PCR. Lubricin immunostaining was assessed in synovial membrane and osteochondral sections in the experimental model.

Results: Lubricin concentrations increased in synovial fluid following induction of OA, peaking at 21 days post-operatively in OA joints vs sham-operated controls (331 ± 69 μg/mL vs 110 ± 19 μg/mL, P = 0.001). Lubricin concentrations also increased in horses with naturally occurring OA as compared to control joints (152 ± 32 μg/mL vs 68 ± 4 μg/mL, P = 0.003). Synovial membrane PRG4 expression increased nearly 2-fold in naturally occurring OA (P = 0.003), whereas cartilage PRG4 expression decreased 2.5-fold (P = 0.025). Lubricin immunostaining was more pronounced in synovial membrane from OA joints as compared to controls, with intense lubricin localization to sites of cartilage damage.

Conclusions: Although PRG4 gene expression decreases in OA cartilage, synovial membrane PRG4 expression, synovial fluid lubricin concentrations and lubricin immunostaining all increase in an equine OA model. Lubricin may be elevated to protect joints from post-traumatic OA.

Citing Articles

Delayed lubricin injection improves cartilage repair tissue quality in an in vivo rabbit osteochondral defect model.

Yoon D, Vishwanath K, Dankert J, Butler J, Azam M, Gianakos A bioRxiv. 2025; .

PMID: 39974965 PMC: 11839081. DOI: 10.1101/2025.02.06.636825.


Correlation of fecal microbiome dysregulation to synovial transcriptome in an equine model of obesity associated osteoarthritis.

Chow L, Kawahisa-Piquini G, Bass L, Hendrickson D, Patel A, Rockow M Ann Transl Med. 2025; 12(6):112.

PMID: 39817240 PMC: 11729816. DOI: 10.21037/atm-24-109.


Characterization of the single cell landscape in normal and osteoarthritic equine joints.

Ammons D, Chow L, Goodrich L, Bass L, Larson B, Williams Z Ann Transl Med. 2024; 12(5):88.

PMID: 39507442 PMC: 11534742. DOI: 10.21037/atm-24-40.


Interactions and Trends of Interleukins, PAI-1, CRP, and TNF-α in Inflammatory Responses during the Perioperative Period of Joint Arthroplasty: Implications for Pain Management-A Narrative Review.

Cocea A, Stoica C J Pers Med. 2024; 14(5).

PMID: 38793119 PMC: 11122505. DOI: 10.3390/jpm14050537.


Recombinant manufacturing of multispecies biolubricants.

Colville M, Huang L, Schmidt S, Chen K, Vishwanath K, Su J bioRxiv. 2024; .

PMID: 38746339 PMC: 11092771. DOI: 10.1101/2024.05.05.592580.


References
1.
Shine K, Spector M . The presence and distribution of lubricin in the caprine intervertebral disc. J Orthop Res. 2008; 26(10):1398-406. DOI: 10.1002/jor.20614. View

2.
Ludwig T, McAllister J, Lun V, Wiley J, Schmidt T . Diminished cartilage-lubricating ability of human osteoarthritic synovial fluid deficient in proteoglycan 4: Restoration through proteoglycan 4 supplementation. Arthritis Rheum. 2012; 64(12):3963-71. DOI: 10.1002/art.34674. View

3.
Frisbie D, Cross M, McIlwraith C . A comparative study of articular cartilage thickness in the stifle of animal species used in human pre-clinical studies compared to articular cartilage thickness in the human knee. Vet Comp Orthop Traumatol. 2006; 19(3):142-6. View

4.
Ruan M, Erez A, Guse K, Dawson B, Bertin T, Chen Y . Proteoglycan 4 expression protects against the development of osteoarthritis. Sci Transl Med. 2013; 5(176):176ra34. PMC: 3804124. DOI: 10.1126/scitranslmed.3005409. View

5.
Marcelino J, Carpten J, Suwairi W, Gutierrez O, Schwartz S, Robbins C . CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet. 1999; 23(3):319-22. DOI: 10.1038/15496. View